JACC:儿童家族性高胆固醇血症的筛查

2015-09-09 崔倩 译 MedSci原创

未经治疗的家族性高胆固醇血症(FH)人群与那些未受影响的人群相比,心血管并发症风险升高了100倍。但目前儿童的普遍筛查鉴定FH的数据比较缺乏。本研究试图从一个血清总胆固醇(TC)浓度升高的儿童队列中进行遗传鉴定FH,在一个全国性的普遍筛查高胆固醇血症的研究中进行检测。在1989年和2009年之间,在斯洛文尼亚出生的TC>6 mmol/l(231.7mg/dl)或>5 mmol/l(19

未经治疗的家族性高胆固醇血症(FH)人群与那些未受影响的人群相比,心血管并发症风险升高了100倍。但目前儿童的普遍筛查鉴定FH的数据比较缺乏。

本研究试图从一个血清总胆固醇(TC)浓度升高的儿童队列中进行遗传鉴定FH,该研究在一个全国性的普遍筛查高胆固醇血症的研究中进行检测。

研究选取了1989年至2009年间在斯洛文尼亚出生的TC>6 mmol/l(231.7mg/d)的,或>5 mmol/l(193.1mg/dl但早发心血管并发症家族史是阳性的儿童,共272名。这些儿童在5岁时接受国家高胆固醇血症普遍筛查并对LDLR,PCSK9,APOB,和APOE的基因变异进行了确定。

在上文中提到的儿童中,57.0%携带了FH疾病导致的变异:38.6%为LDLR变异,18.4%为APOB变异,无PCSK9变异情况。9例新型致病变异进行了鉴定,LDLR变异有8例,1例APOB变异。其余的参与者中,43.6%携带的APOE E4亚型。在2009至2013年间,普遍筛查项目FH的预计检出率为53.6%(95%可信区间为34.5%至72.8%),峰值在2013年较高估计检出率为96.3%。LDLR,APOB,或APOE E4亚型变异分别发生了48.6%,60.0%,和76.5%,这些患者均为心血管并发症家族史阴性。

国家数据库的普遍筛查高胆固醇血症结果表明大多数参与者基因证实为FH。家族史的数据通过选择和级联筛选可能不足以可靠地鉴定患者。

原始出处:

Gašper Klančar, Urh Grošelj,Jernej Kovač, et al.Universal Screening for Familial Hypercholesterolemia in Children,JACC,2015.9.8

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853408, encodeId=e4f118534088d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 08 22:45:00 CST 2016, time=2016-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325101, encodeId=c9cd132510127, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380019, encodeId=c2b21380019e5, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629471, encodeId=28d616294e136, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2016-04-08 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853408, encodeId=e4f118534088d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 08 22:45:00 CST 2016, time=2016-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325101, encodeId=c9cd132510127, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380019, encodeId=c2b21380019e5, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629471, encodeId=28d616294e136, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853408, encodeId=e4f118534088d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 08 22:45:00 CST 2016, time=2016-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325101, encodeId=c9cd132510127, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380019, encodeId=c2b21380019e5, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629471, encodeId=28d616294e136, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1853408, encodeId=e4f118534088d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 08 22:45:00 CST 2016, time=2016-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325101, encodeId=c9cd132510127, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380019, encodeId=c2b21380019e5, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629471, encodeId=28d616294e136, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Fri Sep 11 02:45:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-09-11 wetgdt

相关资讯

Eur Heart J:欧洲动脉粥样硬化学会:家族性高胆固醇血症的诊治及靶标

近日,欧洲动脉粥样硬化学会(EAS)发表文章指出,普通人群的家族性高胆固醇血症(FH)的诊断和治疗率均较低,为此,EAS发表了FH预防冠心病的诊治指南与共识,相关文章8月15日在线发表于《欧洲心脏杂志》(Eur Heart J)。【原文下载】 指南指出,依据杂合子FH的理论估计1/500患病率,在大多数国家中FH诊断率低于1%。近期北欧普通人群直接筛查得出的杂合子FH患病

LANCET:PCSK单克隆抗体降低家族性高胆固醇血症患者的低密度脂蛋白胆固醇试验

  背景  1期试验结果显示,抑制蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型丝氨酸蛋白酶(PCSK9)可使低密度脂蛋白胆固醇(LDL-C)水平大幅降低。本研究评价了在他汀类药物的基础上加用PCSK9单克隆抗体REGN727,其不同剂量和给药间隔进一步降低杂合型家族性高胆固醇血症患者LDL-C的有效性和安全性。   方法  这项多中心、随机、安慰剂对照2期试验在美国和加拿大

Lancet:新药Lomitapide有助治疗家族性高胆固醇血症

  11月2日,《柳叶刀》(Lancet)杂志在线发表了一项微粒体甘油三酯转移蛋白抑制剂Lomitapide治疗纯合子家族性高胆固醇血症(HoFH)的研究,结果表明,Lomitapide对于治疗HoFH有重要价值。   该研究为一项单盲、开放标签、临床Ⅲ期研究,HoFH患者从基线前6周开始当前的降脂治疗,并至少维持至第26周。Lomitapide的剂量根据安全性和耐受性逐渐从每天5 m

EHJ:儿童和青少年家族性高胆固醇血症的管理

家族性高胆固醇血症(FH)是早产儿冠心病(CHD)的常见遗传原因。全球每分钟就有一例FH婴儿出生。如果在儿童早期阶段进行诊断和治疗,FH个体可有正常人的预期寿命。5月25日,《欧洲心脏杂志》(Eur Heart J)刊文阐述了FH的早期检测和管理策略。FH的诊断文章指出,可通过表型标准和/或遗传诊断或基因检测来诊断FH,前者包括低密度脂蛋白胆固醇(L

Eur Heart J:纯合子家族性高胆固醇血症临床管理指南

近日,欧洲动脉粥样硬化学会(EAS)发布了纯合子家族性高胆固醇血症(HoFH)临床管理指南,全文7月22日在线发表于《欧洲心脏杂志》(Eur Heart J)。以下为指南摘要内容。 诊断 指南建议, HoFH的早期诊断并及时启动饮食和降脂治疗至关重要。基因学检测可确诊,但如果不可用,低密度脂蛋白胆固醇(LDL-C)显著升高和<10岁出现皮肤或肌腱黄色瘤,或者未经处理的LDL-C水平升高伴有父母

Heart:多种策略确定家族性高胆固醇血症

  英国学者的一项研究表明,伴有腱黄色瘤(TX)的确定性家族性高胆固醇血症(FH)患者应行基因分型。在可疑性FH患者中,冠心病病史或粥样斑块影像学证据是确认可能伴有单基因FH患者的最佳方法。论文于2012年12月4日在线发表于《心脏》(Heart)杂志。   此项研究共纳入204例年龄为(55±14)岁的患者,其中36%伴有TX,21%伴有冠心病[低密度脂蛋白胆固醇(LDL-C)为(6.20±2